Please use this identifier to cite or link to this item: http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/6997
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorKIKKERI, RAGHAVENDRAen_US
dc.contributor.authorK.R., REMYAen_US
dc.date.accessioned2022-05-26T04:22:23Z-
dc.date.available2022-05-26T04:22:23Z-
dc.date.issued2022-05-
dc.identifier.citation54en_US
dc.identifier.urihttp://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/6997-
dc.description.abstractOligo-iduronic acids are linear heparan sulfate (HS) mimic that can do many functions of native HS counterpart. Among them, tri-iduronic acid analogs have shown potential antiheparanase, anti-viral activity, and HB-EGF-mediated cancer cell targeting. Hence, synthesizing these analogs in a large scale is essential for extensive biological studies. Here, we report the synthesis of I-34 and IAC-3 oligosaccharides in 24 steps utilizing linear synthetic strategies on a gram scale. Importantly, we found that selective deprotection of acetate group in acidic conditions and TMSSPh mediated thio-donor reaction goes well in small-scale batches over large-scale reaction. Furthermore, the microwave method of sulfation and LH-20, sodium resin, and Sephadex column improve the overall yield of the final compounds. We also designed an auto-fluorescent gold nanocluster of size (2 nm) and gold nanoparticles of size (10 and 20 nm) to functionalize I-34 to study size-dependent fast and selective uptake by EGFR overexpressed cancer cells.en_US
dc.language.isoenen_US
dc.subjectIdoronic acid synthesisen_US
dc.titleSynthesis of Sulfated Tri-Iduronic acid Analogs to Target Canceren_US
dc.typeThesisen_US
dc.type.degreeBS-MSen_US
dc.contributor.departmentDept. of Chemistryen_US
dc.contributor.registration20171031en_US
Appears in Collections:MS THESES

Files in This Item:
File Description SizeFormat 
R3220171031.pdfMS thesis on the synthesis of sulfated idoronic acid trisaccharide4.45 MBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.